BRPI1008023A2 - forma de dosagem sólida - Google Patents

forma de dosagem sólida

Info

Publication number: BRPI1008023A2
Authority: BR; Brazil
Prior art keywords: dosage form; solid dosage; solid; dosage
Prior art date: 2009-02-13

Application number

BRPI1008023A

Other languages

English (en)

Inventor

Colin J Meyer

Jiang Zhang

Original Assignee

Reata Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-13

Filing date

2010-02-12

Publication date

2016-03-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42335073&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1008023(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-02-12 Application filed by Reata Pharmaceuticals Inc filed Critical Reata Pharmaceuticals Inc

2016-03-15 Publication of BRPI1008023A2 publication Critical patent/BRPI1008023A2/pt

2019-12-31 Publication of BRPI1008023B1 publication Critical patent/BRPI1008023B1/pt

2023-04-11 Publication of BRPI1008023B8 publication Critical patent/BRPI1008023B8/pt

Links

239000007909 solid dosage form Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI1008023A 2009-02-13 2010-02-12 Forma de dosagem sólida BRPI1008023B8 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US15260809P	2009-02-13	2009-02-13
PCT/US2010/024127 WO2010093944A2 (en)	2009-02-13	2010-02-12	Delayed release, oral dosage compositions that contain amorphous cddo-me

Publications (3)

Publication Number	Publication Date
BRPI1008023A2 true BRPI1008023A2 (pt)	2016-03-15
BRPI1008023B1 BRPI1008023B1 (pt)	2019-12-31
BRPI1008023B8 BRPI1008023B8 (pt)	2023-04-11

Family

ID=42335073

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1008023A BRPI1008023B8 (pt)	2009-02-13	2010-02-12	Forma de dosagem sólida

Country Status (30)

Country	Link
US (2)	US8747901B2 (pt)
EP (2)	EP2395979B1 (pt)
JP (1)	JP5775464B2 (pt)
KR (2)	KR20140016441A (pt)
CN (2)	CN105232471A (pt)
AU (1)	AU2010213594B2 (pt)
BR (1)	BRPI1008023B8 (pt)
CA (1)	CA2752048C (pt)
CO (1)	CO6361904A2 (pt)
CY (2)	CY1119595T1 (pt)
DK (2)	DK2395979T3 (pt)
EA (1)	EA023652B1 (pt)
ES (2)	ES2646816T3 (pt)
HK (1)	HK1220130A1 (pt)
HR (2)	HRP20171639T1 (pt)
HU (2)	HUE035013T2 (pt)
IL (1)	IL214258A (pt)
LT (2)	LT3254675T (pt)
MX (1)	MX2011008344A (pt)
MY (1)	MY173715A (pt)
NO (1)	NO2395979T3 (pt)
NZ (1)	NZ594488A (pt)
PL (2)	PL3254675T3 (pt)
PT (2)	PT2395979T (pt)
SG (1)	SG173601A1 (pt)
SI (2)	SI2395979T1 (pt)
SM (2)	SMT201900432T1 (pt)
TR (1)	TR201909743T4 (pt)
WO (1)	WO2010093944A2 (pt)
ZA (1)	ZA201105630B (pt)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6326507B1 (en)	1998-06-19	2001-12-04	Trustees Of Dartmouth College	Therapeutic compounds and methods of use
ME03529B (me)	2008-01-11	2020-04-20	Reata Pharmaceuticals Inc	Sintetički triterpenoidi i metode njihove upotrebe u tretmanu bolesti
HUE033288T2 (en)	2008-04-18	2017-11-28	Reata Pharmaceuticals Inc	Antioxidant inflammation modulators: C-17 homologated oleic acid derivatives
RS58392B1 (sr)	2008-04-18	2019-04-30	Reata Pharmaceuticals Inc	Antioksidantni modulatori inflamacije: derivati oleanoličke kiseline sa amino i drugim modifikacijama na c-17
TW201006474A (en)	2008-04-18	2010-02-16	Reata Pharmaceuticals Inc	Natural products including an anti-flammatory pharmacore and methods of use
EP2279197B1 (en)	2008-04-18	2014-11-05	Reata Pharmaceuticals, Inc.	Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the c-ring
ES2449396T3 (es)	2008-07-22	2014-03-19	Trustees Of Dartmouth College	Cianoenonas monocíclicas y métodos de uso de las mismas
SG173601A1 (en)	2009-02-13	2011-09-29	Reata Pharmaceuticals Inc	Delayed release, oral dosage compositions that contain amorphous cddo-me
AU2011240690C1 (en)	2010-04-12	2014-11-06	Reata Pharmaceuticals Holdings, LLC	Method of treating obesity using antioxidant inflammation modulators
ES2653717T3 (es)	2010-12-17	2018-02-08	Reata Pharmaceuticals, Inc.	Pirazolil- y pirimidinil-enonas tricíclicas como moduladores antioxidantes de la inflamación
EA026847B1 (ru)	2011-03-11	2017-05-31	Рита Фармасьютикалз, Инк.	C4-монометилтритерпеноидные производные и способы их применения
CN103156861B (zh) *	2011-12-08	2015-11-25	陈丽梅	齐敦果酸衍生物及其可药用盐在治疗糖尿病眼病中的应用
US9504679B2 (en)	2011-12-19	2016-11-29	Bjoern Colin Kahrs	Pharmaceutical compositions comprising glitazones and Nrf2 activators
US20130158077A1 (en)	2011-12-19	2013-06-20	Ares Trading S.A.	Pharmaceutical compositions
EP2841445B1 (en)	2012-04-27	2017-06-14	Reata Pharmaceuticals, Inc.	2.2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof
US8981144B2 (en)	2012-05-08	2015-03-17	Trustees Of Dartmouth College	Method for synthesizing 2-cyano-3,12-dioxoolean-1, 9(11)-dien-28-oic acid methyl ester and derivatives thereof
US8921419B2 (en)	2012-05-08	2014-12-30	Trustees Of Dartmouth College	Triterpenoids and compositions containing the same
US9556222B2 (en)	2012-06-15	2017-01-31	Reata Pharmaceuticals, Inc.	A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof
US9278912B2 (en)	2012-09-10	2016-03-08	Reata Pharmaceuticals, Inc.	C13-hydroxy derivatives of oleanolic acid and methods of use thereof
US9512094B2 (en)	2012-09-10	2016-12-06	Reata Pharmaceuticals, Inc.	C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
TWI630212B (zh)	2012-09-10	2018-07-21	瑞塔醫藥有限責任公司	丁香油素（ｏｌｅａｎｏｌｉｃａｃｉｄ）之ｃ１７－烷二基與烯二基衍生物及其使用方法
TWI649330B (zh)	2013-04-24	2019-02-01	艾伯維有限公司	甲基巴多索龍之２，２－二氟丙醯胺衍生物、其多晶形及其使用方法
IL285832B2 (en)	2013-08-23	2024-01-01	Reata Pharmaceuticals Inc	Methods of treating and preventing endothelial dysfunction using bardoxolone methyl or analogs thereof
EP3212195A4 (en)	2014-10-31	2018-06-06	The Regents of The University of California	Compositions and methods for treating hiv-associated cognitive dysfunction
AU2016219109B2 (en)	2015-02-12	2020-05-14	Reata Pharmaceuticals, Inc.	Imidazolyl tricyclic enones as antioxidant iflammation modulators
BR112018005861B1 (pt)	2015-09-23	2022-11-22	Reata Pharmaceuticals, Inc	Compostos derivados de ácido oleanólico modificado com c4 para a inibição de il-17, composição farmacêutica e usos terapêuticos dos ditos compostos
BR112019009256A2 (pt)	2016-11-08	2019-07-16	Reata Pharmaceuticals, Inc.	métodos para tratar síndrome de alport usando bardoxolona metil ou análogos do mesmo
TWI831738B (zh)	2016-12-16	2024-02-11	美商瑞塔醫藥有限責任公司	用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物
WO2019014412A1 (en)	2017-07-13	2019-01-17	Pliva Hrvatska D.O.O.	NOVEL CRYSTALLINE POLYMORPHIC FORMS OF METHYL BARDOXOLONE
EP3773509B1 (en)	2018-04-06	2023-11-01	Capsugel Belgium NV	Spray drying process for low aspect ratio particles comprising poly[(methyl methacrylate)-co-(methacrylic acid)]
US11993574B2 (en)	2018-06-15	2024-05-28	Reata Pharmaceuticals, Inc	Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma
US12060340B2 (en)	2018-06-20	2024-08-13	Reata Pharmaceuticals, Inc	Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith
WO2020111089A1 (ja)	2018-11-27	2020-06-04	協和キリン株式会社	医薬組成物
SG11202112464PA (en) *	2019-05-31	2021-12-30	Denali Therapeutics Inc	Modified release formulation of a pyrimidinylamino-pyrazole compound, and methods of treatment
CN120248001A (zh)	2019-07-19	2025-07-04	里亚塔医药公司	C17极性的-取代的杂芳族合成三萜类化合物及其使用方法
CA3177913A1 (en)	2020-05-09	2021-11-18	Deborah FERGUSON	Methods of treating covid-19 using bardoxolone methyl or analogs thereof
US20240293351A1 (en)	2020-12-11	2024-09-05	Reata Pharmaceuticals Holdings, LLC	Methods of administering synthetic triterpenoids
CN114558019A (zh) *	2022-03-26	2022-05-31	中国科学院昆明动物研究所	一种Rab13基因抑制剂及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6326507B1 (en)	1998-06-19	2001-12-04	Trustees Of Dartmouth College	Therapeutic compounds and methods of use
US7435755B2 (en) *	2000-11-28	2008-10-14	The Trustees Of Dartmouth College	CDDO-compounds and combination therapies thereof
JP2008110962A (ja) *	2006-08-02	2008-05-15	Santen Pharmaceut Co Ltd	Ｎｒｆ２活性化物質を有効成分として含む角結膜障害の予防または治療剤
JP4315182B2 (ja) *	2006-10-30	2009-08-19	ミツミ電機株式会社	カメラモジュール
JP2008247898A (ja)	2007-03-08	2008-10-16	Santen Pharmaceut Co Ltd	トリテルペノイドを有効成分として含有する酸化ストレスが関連する眼疾患の予防又は治療剤
US8088824B2 (en)	2007-08-15	2012-01-03	Reata Pharmaceuticals Inc.	Forms of CDDO methyl ester
ME03529B (me) *	2008-01-11	2020-04-20	Reata Pharmaceuticals Inc	Sintetički triterpenoidi i metode njihove upotrebe u tretmanu bolesti
SG173601A1 (en)	2009-02-13	2011-09-29	Reata Pharmaceuticals Inc	Delayed release, oral dosage compositions that contain amorphous cddo-me

2010
- 2010-02-12 SG SG2011057122A patent/SG173601A1/en unknown
- 2010-02-12 HR HRP20171639TT patent/HRP20171639T1/hr unknown
- 2010-02-12 JP JP2011550279A patent/JP5775464B2/ja active Active
- 2010-02-12 AU AU2010213594A patent/AU2010213594B2/en active Active
- 2010-02-12 KR KR1020147001850A patent/KR20140016441A/ko not_active Withdrawn
- 2010-02-12 US US13/201,398 patent/US8747901B2/en not_active Expired - Fee Related
- 2010-02-12 SI SI201031570T patent/SI2395979T1/sl unknown
- 2010-02-12 TR TR2019/09743T patent/TR201909743T4/tr unknown
- 2010-02-12 MY MYPI2011003694A patent/MY173715A/en unknown
- 2010-02-12 PT PT107042988T patent/PT2395979T/pt unknown
- 2010-02-12 CA CA2752048A patent/CA2752048C/en active Active
- 2010-02-12 MX MX2011008344A patent/MX2011008344A/es active IP Right Grant
- 2010-02-12 EA EA201190092A patent/EA023652B1/ru not_active IP Right Cessation
- 2010-02-12 KR KR1020117021250A patent/KR101483203B1/ko active Active
- 2010-02-12 HU HUE10704298A patent/HUE035013T2/en unknown
- 2010-02-12 EP EP10704298.8A patent/EP2395979B1/en active Active
- 2010-02-12 ES ES10704298.8T patent/ES2646816T3/es active Active
- 2010-02-12 ES ES17181174T patent/ES2731601T3/es active Active
- 2010-02-12 SM SM20190432T patent/SMT201900432T1/it unknown
- 2010-02-12 NO NO10704298A patent/NO2395979T3/no unknown
- 2010-02-12 SM SM20170527T patent/SMT201700527T1/it unknown
- 2010-02-12 PT PT17181174T patent/PT3254675T/pt unknown
- 2010-02-12 SI SI201031906T patent/SI3254675T1/sl unknown
- 2010-02-12 LT LTEP17181174.8T patent/LT3254675T/lt unknown
- 2010-02-12 BR BRPI1008023A patent/BRPI1008023B8/pt active IP Right Grant
- 2010-02-12 WO PCT/US2010/024127 patent/WO2010093944A2/en not_active Ceased
- 2010-02-12 NZ NZ594488A patent/NZ594488A/xx unknown
- 2010-02-12 DK DK10704298.8T patent/DK2395979T3/da active
- 2010-02-12 PL PL17181174T patent/PL3254675T3/pl unknown
- 2010-02-12 CN CN201510540397.8A patent/CN105232471A/zh active Pending
- 2010-02-12 EP EP17181174.8A patent/EP3254675B1/en active Active
- 2010-02-12 DK DK17181174.8T patent/DK3254675T3/da active
- 2010-02-12 HU HUE17181174A patent/HUE044005T2/hu unknown
- 2010-02-12 PL PL10704298T patent/PL2395979T3/pl unknown
- 2010-02-12 LT LTEP10704298.8T patent/LT2395979T/lt unknown
- 2010-02-12 CN CN201080007105XA patent/CN102387789A/zh active Pending
2011
- 2011-07-24 IL IL214258A patent/IL214258A/en active IP Right Grant
- 2011-07-29 ZA ZA2011/05630A patent/ZA201105630B/en unknown
- 2011-08-09 CO CO11100847A patent/CO6361904A2/es not_active Application Discontinuation
2014
- 2014-04-30 US US14/266,031 patent/US9155721B2/en active Active
2016
- 2016-07-13 HK HK16108241.2A patent/HK1220130A1/zh unknown
2017
- 2017-11-13 CY CY20171101183T patent/CY1119595T1/el unknown
2019
- 2019-06-17 HR HRP20191092 patent/HRP20191092T1/hr unknown
- 2019-07-17 CY CY20191100761T patent/CY1122066T1/el unknown

Also Published As

Publication number	Publication date
WO2010093944A3 (en)	2011-08-11
NZ594488A (en)	2013-10-25
CO6361904A2 (es)	2012-01-20
HRP20171639T1 (hr)	2017-12-15
EA023652B1 (ru)	2016-06-30
HUE035013T2 (en)	2018-05-02
SG173601A1 (en)	2011-09-29
WO2010093944A2 (en)	2010-08-19
EP3254675A1 (en)	2017-12-13
CA2752048A1 (en)	2010-08-19
SI2395979T1 (sl)	2017-12-29
KR101483203B1 (ko)	2015-01-15
PT2395979T (pt)	2017-11-16
JP2012518008A (ja)	2012-08-09
BRPI1008023B8 (pt)	2023-04-11
MY173715A (en)	2020-02-18
EA201190092A1 (ru)	2012-02-28
DK2395979T3 (da)	2017-11-27
PT3254675T (pt)	2019-06-14
US20140235711A1 (en)	2014-08-21
SMT201900432T1 (it)	2019-09-09
IL214258A0 (en)	2011-09-27
PL3254675T3 (pl)	2019-09-30
SMT201700527T1 (it)	2018-01-11
LT2395979T (lt)	2017-12-11
CN105232471A (zh)	2016-01-13
HRP20191092T1 (hr)	2019-11-29
HK1220130A1 (zh)	2017-04-28
KR20140016441A (ko)	2014-02-07
US20120022156A1 (en)	2012-01-26
NO2395979T3 (pt)	2018-01-20
EP2395979B1 (en)	2017-08-23
IL214258A (en)	2017-06-29
MX2011008344A (es)	2011-09-29
AU2010213594B2 (en)	2013-11-14
DK3254675T3 (da)	2019-06-24
CY1122066T1 (el)	2020-11-25
CA2752048C (en)	2014-11-25
US8747901B2 (en)	2014-06-10
EP3254675B1 (en)	2019-05-15
US9155721B2 (en)	2015-10-13
EP2395979A2 (en)	2011-12-21
SI3254675T1 (sl)	2019-08-30
ES2731601T3 (es)	2019-11-18
AU2010213594A1 (en)	2011-08-18
ES2646816T3 (es)	2017-12-18
HUE044005T2 (hu)	2019-09-30
CY1119595T1 (el)	2018-03-07
PL2395979T3 (pl)	2018-02-28
ZA201105630B (en)	2012-04-25
CN102387789A (zh)	2012-03-21
BRPI1008023B1 (pt)	2019-12-31
LT3254675T (lt)	2019-06-25
KR20110118721A (ko)	2011-10-31
TR201909743T4 (tr)	2019-07-22
JP5775464B2 (ja)	2015-09-09

Legal Events

Date	Code	Title	Description
2017-10-10	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-05-15	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2018-10-02	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2019-07-30	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2019-11-19	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2019-12-31	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/02/2010, OBSERVADAS AS CONDICOES LEGAIS.
2023-04-11	B25A	Requested transfer of rights approved	Owner name: REATA PHARMACEUTICALS HOLDINGS, LLC (US)

Publication	Publication Date	Title
BR112013014361A2 (pt)	2016-09-27	forma de dosagem
DK2427449T3 (da)	2013-04-22	Vinylindazolylforbindelser
BR112012006859A2 (pt)	2019-09-24	compostos
DK2414015T3 (da)	2021-12-06	Laryngoskopsystem
DK2411442T4 (da)	2021-12-06	Umættet polyesterresin
DE112010004215A5 (de)	2012-08-23	Hydrostataktor
DE112010002949A5 (de)	2012-09-06	Kupplungstastpunkte
EP2469625A4 (en)	2015-11-04	OMNIBUS BAR
EP2491340A4 (en)	2014-12-24	TELEMETRY PHOTOGRAPHIC APPARATUS
EP2509489A4 (en)	2015-04-01	SPRINKLER FOR EARLY HEEL REMOVAL
EP2440486A4 (en)	2013-09-25	CABLE RETRACTION SYSTEM
BRPI1005525A2 (pt)	2016-02-23	compostos de azaazuleno
BRPI1008827A2 (pt)	2016-02-23	deisobutenizador
BRPI1014968A2 (pt)	2016-12-13	subalargador
DE112010002728A5 (de)	2012-06-21	Turboinhalator
DE112010004249A5 (de)	2012-11-29	Spindelaktor
EP2446176A4 (en)	2016-12-14	CYLINDER SEAL
DE112009005462T8 (de)	2013-03-28	Lenkungsssteuervorrichtung
BRPI1008070A2 (pt)	2016-03-15	tricianoboratos
BR112012031102A2 (pt)	2015-09-22	forma de dosagem oral sólida
DK2483126T3 (da)	2015-06-22	Skinnekøretøj
BRPI0807882A2 (pt)	2014-06-17	Forma de dosagem
DK2506968T3 (da)	2020-11-23	Faujasit-zeolit
DK2488157T3 (da)	2021-01-25	Forbedrede formuleringer
EP2454221A4 (en)	2012-05-23	cineole